Prof. Rautou, France, discusses a critical component of the diagnosis and management of NASH: biomarkers. There are 2 aspects: fibrosis and diagnosis. Diagnosis is a field of investigations. Microvesicles could play a role.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In